Assura PLC

Director's Dealing • Apr 16, 2020

National Storage Mechanism | Additional information

RNS Number : 8929J

Assura PLC

16 April 2020

16 April 2020

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company has been notified that in respect of the interim dividend paid on 15 April 2020, the following PDMRs acquired ordinary shares of 10 pence each in the Company through their participation in the Company's Scrip Dividend Alternative:

PDMR	Date Acquired	Number of shares acquired	Purchase price per Share
Ed Smith	15 April 2020	759	£0.69
Jayne Cottam	15 April 2020	879	£0.69

The Notification of Dealing Form for Mr Smith and Mrs Cottam can be found below.

This notification is made in accordance with the Market Abuse Regulation.

-ENDS-

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ed Smith

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Purchase of shares under the Scrip Dividend Alternative

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.69 GBP	759

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price	Aggregate Volume	Aggregate Total
£0.69 GBP	759	£523.71 GBP

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

XLON

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jayne Cottam

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Purchase of shares under the Scrip Dividend Alternative

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.69 GBP	879

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price	Aggregate Volume	Aggregate Total
£0.69 GBP	879	£606.51 GBP

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

XLON

For more information, please contact:

Assura plc	Tel: 01925 420660
Orla Ball, Company Secretary David Purcell, Head of Financial Reporting
Finsbury Gordon Simpson James Thompson	Tel: 0207 251 3801

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

Assura plc LEI code: 21380026T19N2Y52XF7

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGCGDSISBDGGL